Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by MAI Capital Management

MAI Capital Management lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 60,300 shares of the pharmacy operator’s stock after selling 2,600 shares during the period. MAI Capital Management’s holdings in Walgreens Boots Alliance were worth $540,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Marathon Trading Investment Management LLC boosted its position in shares of Walgreens Boots Alliance by 22.0% during the 3rd quarter. Marathon Trading Investment Management LLC now owns 72,000 shares of the pharmacy operator’s stock worth $645,000 after purchasing an additional 13,000 shares during the period. Altrius Capital Management Inc boosted its position in shares of Walgreens Boots Alliance by 76.6% during the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock worth $3,947,000 after buying an additional 190,996 shares during the period. Tokio Marine Asset Management Co. Ltd. grew its stake in shares of Walgreens Boots Alliance by 21.8% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 25,343 shares of the pharmacy operator’s stock valued at $227,000 after buying an additional 4,534 shares in the last quarter. OLD Second National Bank of Aurora raised its holdings in shares of Walgreens Boots Alliance by 35.1% in the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 1,185 shares during the period. Finally, Aptus Capital Advisors LLC lifted its stake in Walgreens Boots Alliance by 37.6% during the 3rd quarter. Aptus Capital Advisors LLC now owns 14,445 shares of the pharmacy operator’s stock worth $129,000 after acquiring an additional 3,950 shares in the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on WBA shares. Barclays boosted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Jefferies Financial Group dropped their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Evercore ISI increased their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday, October 16th. Finally, Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Price Performance

WBA stock opened at $8.66 on Friday. The business has a 50 day moving average price of $9.14 and a 200 day moving average price of $11.59. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The stock has a market cap of $7.49 billion, a price-to-earnings ratio of -0.87, a PEG ratio of 1.09 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s revenue was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.67 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 11.55%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.